Cell Therapy Account Management - North

Iovance Biotherapeutics , Inc. is the global leader in innovating, developing, and delivering tumor infiltrating lymphocyte (TIL) cell therapies for patients with solid tumors. Amtagvi® (lifileucel) is the first FDA-approved, one-time treatment for previously treated advanced melanoma, now approved in three global markets and available at more than 95 authorized treatment centers. The Iovance TIL platform spans registrational trials and next‑generation programs in additional solid tumors, including gene‑edited and IL‑12 tethered TIL therapies, next‑generation IL‑2, and precision immuno‑oncology approaches.

As the first and only company to take TIL therapy from concept to a broadly accessible commercial treatment, Iovance operates as an end‑to‑end cell therapy company, anchored by fully owned, centralized U.S.

-based manufacturing that is scaled to serve thousands of cancer patients worldwide each year.

For more information, please visit  .

Amtagvi® and its accompanying design marks, Proleukin ® , Iovance ® , and Iovance Cares™ are trademarks and registered trademarks of Iovance Biotherapeutics, Inc. or its subsidiaries. All other trademarks and registered trademarks are the property of their respective owners.

Information on Iovance’s broad, industry‑leading patent portfolio is available on the Intellectual Property page on  .

Amtagvi™ is the best‑in‑class cell therapy treatment for advanced melanoma. The Cell Therapy Account Management (CTAM) will be responsible for driving Amtagvi demand by building a robust referral network between community practices and academic centers; enable early patient identification and streamline referral pathways; and collaborate with internal teams to enhance scientific and operational excellence in cell therapy account management.

To succeed in this role, you will use prior experience to optimize territory strategy in the oncology rare disease space and have demonstrated experience influencing others and building relationships. Additional competencies include experience with immunotherapy and solid tumor cancer, as well as prior launch experience, demonstrated ability to drive demand, pull through, and sustain the growth of Amtagvi™.

• Drive Amtagvi TM demand and appropriate pull‑through at targeted ATCs and serve as a liaison between community oncology practices and internal stakeholders to align initiatives with business and medical objectives.
• Serve as the primary commercial point of contact for the Iovance iPOD at authorized treatment centers offering commercially available Amtagvi TM . Serve as the commercial lead for developing and onboarding a new TIL service line at target ATCs.
• Educate site personnel on clinical and product information for Amtagvi TM .
• Provide knowledge and expertise around Iovance products and processes to all service line customer stakeholders.
• Collaborate with ATC Operations, aligning Iovance Cell Therapy logistics, processes, and operations.
• Provide exemplary customer service while building business relationships with key clinical thought leaders, Amtagvi TM prescribers, and other institutional stakeholders to influence the uptake of Amtagvi TM .
• Develop and maintain applicable disease state, product‑specific (Amtagvi TM ), and competitive landscape knowledge.
• Attend and support professional meetings and congresses regionally and nationally.
• Facilitate engagement with key thought leaders, Cell Therapy prescribers, and other institutional stakeholders.
• Maintain a high level of collaboration and communication with Iovance cross‑functional partners in Market Access, Operations, Quality, Marketing, Medical, and others to ensure appropriate patient…